NIMUSTINE

Nimustine is a nitrosourea alkylating agent that crosses the bloodbrain barrier, used in brain tumors. Side effects include myelosuppression, nausea, and lung toxicity. Only GMP materials will be supplied, logistics all according to GDP.

SKU: 8d327ba2fa59 Category: Tag:

Product Description


Mechanism of Action

NIMUSTINE displays a broad-spectrum, multilayered biochemical interaction profile involving receptor-mediated signalling, enzymatic cascade modulation, mitochondrial redox-balance control, intracellular ion regulation, cytoskeletal architecture influence, and transcription-factor network modulation. Structural analysis suggests potential binding to catalytic residues, allosteric domains and regulatory scaffolding proteins, enabling the compound to alter phosphorylationdephosphorylation kinetics, secondmessenger dynamics (Ca²⁺, IP, DAG, cAMP), ROS buffering capacity, and membrane-potential stabilization.

Depending on experimental concentration and cellular context, NIMUSTINE may adjust ATP turnover rates, affect mitochondrial respiration, reshape metabolic routing, influence vesicular trafficking efficiency, and modulate geneexpression clusters related to cellular survival, stress adaptation, inflammation, and metabolic equilibrium.

Benefits and Advantages

This compound is highly valuable for advanced mechanistic and preclinical research, including:

  • Highresolution receptorligand binding and affinitymapping studies
  • Detailed enzymatickinetic profiling and catalyticpathway deconstruction
  • Mitochondrialfunction analysis, ATPflux tracking and oxidativestress modelling
  • Integrated multiomics investigations (transcriptomics, metabolomics, proteomics, phosphoproteomics)
  • Cytoskeletal and membranedynamics analysis involving actin and tubulin regulation
  • Apoptosis, autophagy, necroptosis, ferroptosis and other celldeath pathway studies
  • Structureactivity relationship (SAR) assessment and molecular optimisation pipelines
  • Advanced pharmacodynamic simulations and mechanistic doseresponse scaling

Side Effects and Risks

Laboratoryobserved risks include:

  • Excessive ROS accumulation and oxidativestress imbalance
  • Mitochondrial hyperactivation or suppression of respiratorychain complexes
  • Disruption of Ca²⁺/Na⁺/K⁺ ionic homeostasis and channel regulation
  • Unintended receptor crosstalk or inhibitory interference
  • membrane-integrity compromise and cytoskeletal destabilisation
  • Dosedependent cytotoxicity leading to apoptosis, autophagy or metabolic collapse
  • Inflammatory transcriptional activation (NF-κB, JNK, p38 MAPK)

Extended exposure may trigger longterm transcriptional rewiring, metabolic reprogramming or epigenetic instability. Use exclusively within controlled laboratory environments following strict biosafety protocols.

Only GMP materials will be supplied, logistics all according to GDP.

Datasheet


Molecular Formula

C9H13ClN6O2

Molecular Weight

272.69 g/mol

CAS Number

42471-28-3

Storage Condition

Store in a cool, dry place. Keep container tightly closed. Protect from moisture and light.

Solubility

Solubility depends on solvent and conditions (e.g., pH). Please contact us for solvent-specific guidance.

Purity

Purity information is available upon request (COA).

Synonym

NIMUSTINE; 42471-28-3; Nimustina; Nimustinum; NSC-758675

IUPAC/Chemical Name

3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-1-(2-chloroethyl)-1-nitrosourea

InChl Key

VFEDRRNHLBGPNN-UHFFFAOYSA-N

InChl Code

InChI=1S/C9H13ClN6O2/c1-6-12-4-7(8(11)14-6)5-13-9(17)16(15-18)3-2-10/h4H,2-3,5H2,1H3,(H,13,17)(H2,11,12,14)

References

https://pubchem.ncbi.nlm.nih.gov/compound/39214;

3D Conformer.

(Click, turn or enlarge)

Download our GMP API Product List.

MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

Download